Inhibition of DNA methyltransferase activity and expression by treatment with the pan-deacetylase inhibitor panobinostat in hepatocellular carcinoma cell lines

被引：0
|
作者：
Steffen Zopf
Matthias Ocker
Daniel Neureiter
Beate Alinger
Susanne Gahr
Markus F Neurath
Pietro Di Fazio
机构：
[1] University Hospital Erlangen,Department of Medicine 1
[2] Paracelsus Medical University,Institute of Pathology
[3] Klinikum Nuremberg Nord,Department of Pneumology
[4] Philipps University Marburg,Institute for Surgical Research
来源：
BMC Cancer | / 12卷
关键词：
DNA methyltransferase; Deacetylase inhibitor; Epigenetics; Transcriptional control; Hepatocellular carcinoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Inhibition of DNA methyltransferase activity and expression by treatment with the pan-deacetylase inhibitor panobinostat in hepatocellular carcinoma cell lines
    Zopf, Steffen
    Ocker, Matthias
    Neureiter, Daniel
    Alinger, Beate
    Gahr, Susanne
    Neurath, Markus F.
    Di Fazio, Pietro
    BMC CANCER, 2012, 12
  • [2] The pan-deacetylase inhibitor panobinostat suppresses the expression of oncogenic miRNAs in hepatocellular carcinoma cell lines
    Henrici, Alexander
    Montalbano, Roberta
    Neureiter, Daniel
    Krause, Michael
    Stiewe, Thorsten
    Slater, Emily Prentice
    Quint, Karl
    Ocker, Matthias
    Di Fazio, Pietro
    MOLECULAR CARCINOGENESIS, 2015, 54 (08) : 585 - 597
  • [3] The pan-deacetylase inhibitor panobinostat affects angiogenesis in hepatocellular carcinoma models via modulation of CTGF expression
    Gahr, Susanne
    Mayr, Christian
    Kiesslich, Tobias
    Illig, Romana
    Neureiter, Daniel
    Alinger, Beate
    Ganslmayer, Marion
    Wissniowski, Till
    Di Fazio, Pietro
    Montalbano, Roberta
    Ficker, Joachim H.
    Ocker, Matthias
    Quint, Karl
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 47 (03) : 963 - 970
  • [4] The pan-deacetylase inhibitor panobinostat modulates the expression of epithelial-mesenchymal transition markers in hepatocellular carcinoma models
    Di Fazio, Pietro
    Montalbano, Roberta
    Quint, Karl
    Alinger, Beate
    Kemmerling, Ralf
    Kiesslich, Tobias
    Ocker, Matthias
    Neureiter, Daniel
    ONCOLOGY LETTERS, 2013, 5 (01) : 127 - 134
  • [5] THE NOVEL PAN-DEACETYLASE INHIBITOR PANOBINOSTAT INDUCES ALTERNATIVE PATHWAYS OF APOPTOSIS IN HEPATOCELLULAR CARCINOMA MODELS
    Di Fazio, P.
    Schneider-Stock, R.
    Wissniowski, T.
    Gahr, S.
    Neureiter, D.
    Ocker, M.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S190 - S191
  • [6] The pan-deacetylase inhibitor panobinostat inhibits growth of hepatocellular carcinoma models by alternative pathways of apoptosis
    Di Fazio, Pietro
    Schneider-Stock, Regine
    Neureiter, Daniel
    Okamoto, Kinya
    Wissniowski, Till
    Gahr, Susanne
    Quint, Karl
    Meissnitzer, Matthias
    Alinger, Beate
    Montalbano, Roberta
    Sass, Gabriele
    Hohenstein, Bernd
    Hahn, Eckhart G.
    Ocker, Matthias
    CELLULAR ONCOLOGY, 2010, 32 (04) : 285 - 300
  • [7] The novel pan-deacetylase inhibitor panobinostat induces alternative pathways of apoptosis in hepatocellular carcinoma models
    Di Fazio, Pietro
    Schneider-Stock, Regine
    Wissniowski, Till
    Gahr, Susanne
    Neureiter, Daniel
    Ocker, Matthias
    CANCER RESEARCH, 2009, 69
  • [8] The pan-deacetylase inhibitor panobinostat induces cell death and synergizes with everolimus in Hodgkin lymphoma cell lines
    Lemoine, Manuela
    Derenzini, Enrico
    Buglio, Daniela
    Medeiros, L. Jeffrey
    Davis, R. Eric
    Zhang, Jiexin
    Ji, Yuan
    Younes, Anas
    BLOOD, 2012, 119 (17) : 4017 - 4025
  • [9] Panobinostat as Pan-deacetylase Inhibitor for the Treatment of Pancreatic Cancer: Recent Progress and Future Prospects
    Avineesh Singh
    Vijay K. Patel
    Deepak K. Jain
    Preeti Patel
    Harish Rajak
    Oncology and Therapy, 2016, 4 (1) : 73 - 89
  • [10] Panobinostat as Pan-deacetylase Inhibitor for the Treatment of Pancreatic Cancer: Recent Progress and Future Prospects
    Singh, Avineesh
    Patel, Vijay K.
    Jain, Deepak K.
    Patel, Preeti
    Rajak, Harish
    ONCOLOGY AND THERAPY, 2016, 4 (01) : 73 - 89
12345